Are There Still Indications for Single Agent High-Dose Interferon-Alpha against AIDS-Associated Kaposi's Sarcoma?

Kaposi M. Idiopathisches multiples pigment Sarkom der Haut. Arch Dermatol Syph 1872; 4: 265–72

Centers for Disease Control. US Public Health Service: Epidemiologic notes and reports. Kaposi's sarcoma and pneumocystic pneumonia among homosexual men. New York City and California. Morbidity and Mortality 1981; 30: 305–8

Ackerman AB Gottlieb GJ . Atlas of the gross and microscopic features. In: Kaposi's sarcoma: a text and atlas. Lea & Fabiger, Philadelphia 1988:29–72

Groopman JE . Biology and therapy of epidemic Kaposi's sarcoma. Cancer 1987; 59: 633–7

Krown SE Real FX Cunningham-Rundles S . Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma. N Engl J Med 1983; 308: 1071–6

Vadhan-Raj S Wong G Gnecco C . Immunological variables as predictors of prognosis in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome. Cancer Res 1986; 46: 417–25

Groopman JE Gottlieb MS Goodman J . Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome. Ann Intern Med 1984; 100: 671–6

Real FX Oettgen HF Krown SE . Kaposi's sarcoma and the acquired immunodeficiency syndrome: Treatment with high and low doses of recombinant leukocyte A interferon. J Clin Oncol 1986:4:544–51

Abrams DI Volberding PA . Alpha interferon therapy of AIDS-associated Kaposi's sarcoma. Semin Oncol 1986; XIII, Suppl.2:433–7

Lane HC Feinberg J Davey V . Anti-retroviral effects of interferon-α in AIDS-associated Kaposi's sarcoma. Lancet 1988; ii: 1218–22

de Wit R Schattenkerk JKME Boucher CAB Bakker PJM Veenhof KHN Danner SA . Clinical and virological effects of high-dose recombinant interferon-alpha in disseminated AIDS-related Kaposi's sarcoma. Lancet 1988; ii: 1214–18

Groopman JE Scadden DT . Interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome. Ann Intern Med 1989; 110: 335–7

Volberding PA Mitsuyasu RT Golando JP Spiegel RJ . Treatment of Kaposi's sarcoma with interferon alpha-2b. Cancer 1987; 59: 620–5

Krown SE Real FX Vadhan-Ray S . Kaposi's sarcoma and the acquired immunodeficiency syndrome. Treatment with recombinant interferon alpha and analysis of prognostic factors. Cancer 1986; 57: 1662–5

Volberding PA Mitsuyasu R. Recombinant interferon alpha in the treatment of acquired immune deficiency syndrome—related Kaposi's sarcoma. Semin Oncol 1985; 12, Suppl.5:2–6

Ho DD Rota TR Kaplan JC . Recombinant human interferon alfa-A suppresses HTLV-III replication in vitro. Lancet 1985; i: 602–4

Lane HC Davey V Kovacs JA . Interferon-α in patients with asymptomatic human immunodeficiency virus (HIV) infection: A randomized, placebo-controlled trial. Ann Intern Med 1990; 112: 805–11

Yarchoan R Mitsuya H Broder S. AIDS therapy. Sci Am 1988; 259: 88–97

Fischl MA Richman DD Grieco MH . The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS related complex: A double-blind, placebo controlled trial. N Engl J Med 1987; 317: 185–91

Yarchoan R Berg G Brouwers P . Response of human immunodeficiency virus-induced neurologic disease to 3‘-azido-3-deoxythymidine. Lancet 1987; i: 132–5

Chiasson RE Leuther MD Allain JP . Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Arch Intern Med 1988; 148: 2151–3

Spector SA Kennedy C McCutchan JA . The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic marker. J Infect Dis 1989; 159: 822–8

Fischl MA Richman DD Hansen N . The safety and efficacy of zidovudine (AZT) in the treatment of mildly symptomatic human immunodeficiency virus type 1. Ann Intern Med 1990; 11: 727–37

Lane HC Falloon J Walker RE . Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi's sarcoma. Ann Intern Med 1989; 111: 41–50

de Wit R Reiss P Bakker PJM Lange JM Danner SA Veenhof KHN . Lack of zidovudine in AIDS-associated Kaposi's sarcoma. AIDS 1989; 3: 847–50

Hartshorn KL Vogt MW Chou T . Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferon. Anti-microb Agents Chemother 1987; 31: 168–72

Krown SE Bundow D Gansbachter B . Interferon-alpha plus zidovudine in AIDS-associated Kaposi's sarcoma: An ongoing phase I trial. Proc Am Soc Clin Oncol 1988; 7: 1

Mullen M Spicehandler D Davidson M Galasso F Spiegel R Grossberg H. Phase I study of combination zidovudine and interferon alfa-2B in patients with AIDS. Proc Am Soc Clin Oncol 1988; 7: 1

Fischl M Reese J Dearmas L , Phase I study of interferon-alpha and AZT in patients with AIDS-related Kaposi's sarcoma. Fourth International Conference on AIDS. Stockholm 1988;Abstr.3133.

de Wit R Danner SA Bakker PJM Lange JMA Schattenkerk JKM Eeftinck Veenhof CHN . Combined zidovudine and interferon-alpha treatment in patients with AIDS-associated Kaposi's sarcoma. J Intern Med 1991; 229: 35–40

Krown SE Gold JWM Niedzwiecki D . Interferon-alpha with zidovudine: Safety, tolerance, and clinical and virologic effects in patients with Kaposi's sarcoma associated with the acquired immunodeficiency syndrome. Ann Intern Med 1990; 112: 812–21

Kovacs JA Deyton L Davey R . Combined zidovudine and interferon-alpha therapy in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1989; 111: 280–7

de Wit R Bakker PJM Veenhof CHN Danner SA . Continued zidovudine and interferon-alpha therapy in Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1990; 112: 306–7

Larder BA Darby G Rickman DD . HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 1989; 243: 1731–4

Hahn BH . Molecular biology of HTLV-III. In: Fauci AS The Acquired Immunodeficiency Syndrome: An update. Ann Intern Med 1985; 102: 800–13

Odajnyk C Muggia F. Treatment of Kaposi's sarcoma: Overview and analysis by clinical setting. J Clin Oncol 1985; 3: 1277–85

Gelmann EP Longo D Lane HC . Combination chemotherapy of disseminated Kaposi's sarcoma in patients with the acquired immune deficiency syndrome. Am J Med 1987; 82: 456–62

Laubenstein LJ Krigel RL Odajnyk CM . Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin and vinblastine. J Clin Oncol 1984; 2: 1115–20

Rieber E Mittelman A Wormser GP . Vincristine and Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann Intern Med 1984; 101: 876

Mintzer DM Real FX Jovinol L . Treatment of Kaposi's sarcoma and trombocytopenia with vincristine in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1985; 102: 200–2

Bakker PJM Danner SA Lange JMA Veenhof CHN . Etoposide for epidemic Kaposi's sarcoma: A phase II study. Eur J Cancer Clin Oncol 1988; 24: 1047–8

Krown SE , Editorial review. AIDS-associated Kaposi's sarcoma: Pathogenesis, clinical course and treatment. AIDS 1988; 2: 71–80

Fischl M Krown S O'Boyle K , Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi's sarcoma. Fourth International Conference on AIDS, Stockholm 1988; Abstra. 4564

Volberding PA . The role of chemotherapy for epidemic Kaposi's sarcoma. Semin Oncol 1987; 14 (suppl 3): 23–6

Lo TCM Salzman FA Smedal MI . Radiotherapy for Kaposi's sarcoma. Cancer 1980; 45: 684–7

Holecek MJ Harwood AR . Radiotherapy of Kaposi's sarcoma. Cancer 1978; 41: 1733–8

Lo TCM Salzman FA Smedal MI . Radiotherapy for Kaposi's sarcoma. Cancer 1980; 45: 684–7

Cooper JS Fried PR Laubenstein LJ . Initial observations of the effect of radiotherapy on epidemic Kaposi's sarcoma. JAMA 1984; 252: 934–5

Cooper JS Fried PR . Defining the role of radiation therapy in the management of epidemic Kaposi's sarcoma. Int J Radiat Oncol Biol Phys 1987:13:35–9

Nobler MP Leddy ME Huh SH . The impact of palliative irradiation of the management of patients with acquired immune deficient syndrome. J Clin Oncol 1987; 5: 107–12

Spittle MF . A simple and effective treatment for AIDS related Kaposi's sarcoma. BMJ 1987; 295: 248–9

Hill DR . The role of radiotherapy for epidemic Kaposi's sarcoma. Semin Oncol 1987; 14,Suppl.3: 19–22

Chak LY Gill PS Levine AM Meyer PR Anselmo JA Petrovich Z. Radiation therapy for acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Clin Oncol 1988; 6: 863–7

Harris JW Reed TA . Kaposi's sarcoma in AIDS: The role of radiation therapy. Front Radiat Ther Oncol 1985; 19: 126–32

Nisce LZ Safai B. Radiation therapy of Kaposi's sarcoma in AIDS. Front Radiat Ther Oncol 1985; 19: 133–37

de Wit R Smit WGJM Veenhof CHN Bakker PJM Oldenburger F Gonzalez D. Palliative radiation therapy for AIDS-associated Kaposi's sarcoma by using a single fraction of 800 cGy. Radiother Oncol 1990; 19: 131–6